Use this medicine in the dose and duration as advised by your doctor. Wash and dry the area. Lie down and gently insert the suppository into the area with or without the use of an applicator as mentioned in the label. You or your care giver may be taught on how to use this medicine at home.
Anomex Suppository is a combination of four medicines: Hydrocortisone, Zinc Oxide, Lidocaine, and Allantoin. Hydrocortisone is a steroid medicine. It blocks the production of certain chemical messengers (prostaglandins) that make the skin red, swollen and itchy. Zinc Oxide has astringent and antiseptic action. Lidocaine is a local anesthetic which works by blocking pain signals from the nerves to the brain thereby decreasing the pain sensation. Allantoin is a skin protectant that works like a moisturizer to soften skin.
Anomex Suppository may be unsafe to use during pregnancy. Animal studies have shown adverse effects on the foetus, however, there are limited human studies. The benefits from use in pregnant women may be acceptable despite the risk. Please consult your doctor.
Anomex Suppository is probably safe to use during lactation.
Limited human data suggests that the drug does not represent a significant risk to the baby.
Anomex Suppository does not usually affect your ability to drive.
Anomex Suppository is probably safe to use in patients with kidney disease. Limited data available suggests that dose adjustment of Anomex Suppository may not be needed in these patients. Please consult your doctor.
Anomex Suppository is probably safe to use in patients with liver disease. Limited data available suggests that dose adjustment of Anomex Suppository may not be needed in these patients. Please consult your doctor.
“The following are the results of on-going survey on 1mg.com for Anomex Suppository. These results only indicate the perceptions of the website users. Please base your medical decisions only on the advice of a doctor or a registered medical professional.”
Information last updated by Dr. Varun Gupta, MD Pharmacology on 8th Mar 2017.